Comparison of Two Silicone Hydrogel Toric Contact Lenses
NCT ID: NCT03392532
Last Updated: 2019-01-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2018-01-04
2018-01-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of a Daily Disposable Toric Silicone Hydrogel Contact Lens
NCT04464044
Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses
NCT05039112
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses
NCT05959200
Clinical Comparison of Toric Contact Lenses Fit Characteristics
NCT05805345
Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses
NCT04254003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AOHG toric, then AO toric
Lotrafilcon B toric contact lenses with HYDRAGLYDE, followed by lotrafilcon B toric contact lenses, as randomized. Each product worn in both eyes for approximately 30 minutes, with a 30-45 minute washout between the removal of Pair 1 and insertion of Pair 2.
Lotrafilcon B toric contact lenses with HYDRAGLYDE
Silicone hydrogel soft contact lenses for astigmatism
Lotrafilcon B toric contact lenses
Silicone hydrogel soft contact lenses for astigmatism
AO toric, then AOHG toric
Lotrafilcon B toric contact lenses, followed by lotrafilcon B toric contact lenses with HYDRAGLYDE, as randomized. Each product worn in both eyes for approximately 30 minutes, with a 30-45 minute washout between the removal of Pair 1 and insertion of Pair 2.
Lotrafilcon B toric contact lenses with HYDRAGLYDE
Silicone hydrogel soft contact lenses for astigmatism
Lotrafilcon B toric contact lenses
Silicone hydrogel soft contact lenses for astigmatism
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lotrafilcon B toric contact lenses with HYDRAGLYDE
Silicone hydrogel soft contact lenses for astigmatism
Lotrafilcon B toric contact lenses
Silicone hydrogel soft contact lenses for astigmatism
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Astigmatism
* Requires contact lenses
* Best corrected visual acuity of 20/25 or better in each eye
Exclusion Criteria
* Any eye surgery that contraindicates contact lens wear, as determined by the Investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alcon, A Novartis Division
Role: STUDY_DIRECTOR
Alcon, A Novartis Division
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
Johns Creek, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLC127-C001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.